- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Alliance Pharma Regulatory News (APH)
Regulatory News for Alliance Pharma (APH)
| Share Price: 36.75 | Bid: 36.25 | Ask: 37.00 | Change: 0.125 (+0.34%) |  | ||||||
| ||||||||||
Exercise of Options
Fri, 16th Sep 2011 14:22
RNS Number : 4126O
Alliance Pharma PLC
16 September 2011
?
|
For immediate release |
16 September 2011 |
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
Exercise of Options and Director's Dealings
Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announces that the Company was notified on 16 September 2011 that Richard Wright, a Director of the Company, exercised options to acquire 136,376 ordinary shares of 1 pence each (Ordinary Shares) at a price of 8.25p per share and 463,624 Ordinary Shares at 8.5 pence per share, all 600,000 of which were subsequently sold on 16 September 2011 at 30.50 pence per share. Following these transactions, Mr Wright holds 190,768 Ordinary Shares in the Company, representing approximately 0.08% of the enlarged issued share capital.
Application has been made for the 600,000 Ordinary Shares to be admitted to AIM, with trading expected to commence on 22 September 2011 ("Admission"). Upon Admission the shares will rank pari passu in all respects with the existing Ordinary Shares of the Company.
After Admission, Alliance will have 239,994,534 Ordinary Shares in issue.
For further information:
Alliance Pharma plc |
+ 44 (0) 1249 466966 |
|
John Dawson, Chief Executive |
|
|
Richard Wright, Finance Director |
|
|
www.alliancepharma.co.uk |
|
|
|
|
Buchanan Communications |
+ 44 (0) 20 7466 5000 |
|
Mark Court / Jessica Fontaine |
|
|
|
|
|
Numis Securities Limited |
+ 44 (0) 20 7260 1000 |
|
Nominated Adviser: Michael Meade / Oliver Cardigan |
|
|
Corporate Broking: David Poutney |
|
Notes to editors:
About Alliance
Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 50 pharmaceutical products and continues to explore opportunities to expand the range.
Alliance's products are prescribed in the treatment of a wide range of conditions and include products used in the treatment of dermatological conditions, in oncology, in childbirth, in the prevention of heart disease, in Parkinson's disease, in nutrition and in nasal infections. Alliance's sales are mainly prescription driven. Its products are distributed to hospitals directly and to pharmaceutical wholesalers, which service both hospital and retail pharmacies with their prescription requirements.
Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.
This information is provided by RNS
The company news service from the London Stock Exchange
| Date | Source | Headline | Category |
|---|---|---|---|
| 15-May-13 07:00 | RNS-R | Proactive Investors Presentation | Company Announcement - General |
| 13-May-13 13:22 | RNS | CULS Conversion and Additional Listing | Company Announcement - General |
| 23-Apr-13 14:36 | RNS | CULS Conversion and Additional Listing | Company Announcement - General |
| 15-Apr-13 12:13 | RNS | CULS Conversion and Additional Listing | Company Announcement - General |
| 11-Apr-13 15:37 | RNS | Annual Report and Accounts | Results and Trading Reports |
| 08-Apr-13 15:51 | RNS | CULS Conversion and Additional Listing | Company Announcement - General |
| 21-Mar-13 07:00 | RNS | Preliminary Results | Results and Trading Reports |
| 18-Mar-13 14:58 | RNS | Notification of Major Interest in Shares | Holding(s) in Company |
| 08-Mar-13 14:51 | RNS | Director Shareholding | Company Announcement - General |
| 04-Mar-13 15:54 | RNS | CULS Conversion and Additional Listing | Company Announcement - General |
| 12-Feb-13 07:00 | RNS | CULS Conversion | Company Announcement - General |
| 30-Jan-13 07:00 | RNS | Notification of Preliminary Results | Advance Notice of Results |
| 22-Jan-13 17:12 | RNS | CULS Conversion and Additional Listing | Company Announcement - General |
| 18-Jan-13 11:50 | RNS | Exercise of Share Options | Company Announcement - General |
| 17-Jan-13 09:44 | RNS | TR-1: Notification of Major Interest in Shares | Holding(s) in Company |
| 15-Jan-13 07:00 | RNS | Pre-Close Trading Update | Company Announcement - General |
| 14-Jan-13 14:13 | RNS | Exercise of Share Options | Company Announcement - General |
| 10-Jan-13 16:23 | RNS | CULS Conversion and Additional Listing | Company Announcement - General |
| 10-Dec-12 11:33 | RNS | CULS Conversion and Additional Listing | Company Announcement - General |
| 07-Dec-12 09:42 | RNS | Exercise of Options | Company Announcement - General |
| 03-Dec-12 12:09 | RNS | Amended Notice - Exercise of Share Options | Company Announcement - General |
| 29-Nov-12 16:13 | RNS | Exercise of Share Options | Company Announcement - General |
| 12-Nov-12 17:15 | RNS | CULS Conversion | Company Announcement - General |
| 30-Oct-12 16:25 | RNS | TR-1: Notification of Major Interest in Shares | Holding(s) in Company |
| 30-Oct-12 15:26 | RNS | Director Sahreholding | Company Announcement - General |
| 26-Oct-12 11:30 | RNS | Director's Dealings | Directors' Dealings |
| 19-Oct-12 16:37 | RNS | Share Options | Company Announcement - General |
| 19-Oct-12 16:04 | RNS | Exercise of Share Options | Company Announcement - General |
| 19-Oct-12 07:00 | RNS | Acquisition | Mergers, Acquisitions and Disposals |
| 12-Sep-12 07:00 | RNS | Interim Results | Results and Trading Reports |
Regulatory news is displayed end of day, each day at 19:00.
